452 related articles for article (PubMed ID: 20044576)
1. O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding.
Yoshida-Moriguchi T; Yu L; Stalnaker SH; Davis S; Kunz S; Madson M; Oldstone MB; Schachter H; Wells L; Campbell KP
Science; 2010 Jan; 327(5961):88-92. PubMed ID: 20044576
[TBL] [Abstract][Full Text] [Related]
2. Like-acetylglucosaminyltransferase (LARGE)-dependent modification of dystroglycan at Thr-317/319 is required for laminin binding and arenavirus infection.
Hara Y; Kanagawa M; Kunz S; Yoshida-Moriguchi T; Satz JS; Kobayashi YM; Zhu Z; Burden SJ; Oldstone MB; Campbell KP
Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17426-31. PubMed ID: 21987822
[TBL] [Abstract][Full Text] [Related]
3. Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy.
Kanagawa M; Nishimoto A; Chiyonobu T; Takeda S; Miyagoe-Suzuki Y; Wang F; Fujikake N; Taniguchi M; Lu Z; Tachikawa M; Nagai Y; Tashiro F; Miyazaki J; Tajima Y; Takeda S; Endo T; Kobayashi K; Campbell KP; Toda T
Hum Mol Genet; 2009 Feb; 18(4):621-31. PubMed ID: 19017726
[TBL] [Abstract][Full Text] [Related]
4. Mouse large can modify complex N- and mucin O-glycans on alpha-dystroglycan to induce laminin binding.
Patnaik SK; Stanley P
J Biol Chem; 2005 May; 280(21):20851-9. PubMed ID: 15788414
[TBL] [Abstract][Full Text] [Related]
5. Aberrant glycosylation of alpha-dystroglycan causes defective binding of laminin in the muscle of chicken muscular dystrophy.
Saito F; Blank M; Schröder J; Manya H; Shimizu T; Campbell KP; Endo T; Mizutani M; Kröger S; Matsumura K
FEBS Lett; 2005 Apr; 579(11):2359-63. PubMed ID: 15848172
[TBL] [Abstract][Full Text] [Related]
6. Glycosylation with ribitol-phosphate in mammals: New insights into the O-mannosyl glycan.
Manya H; Endo T
Biochim Biophys Acta Gen Subj; 2017 Oct; 1861(10):2462-2472. PubMed ID: 28711406
[TBL] [Abstract][Full Text] [Related]
7. N-terminal domain on dystroglycan enables LARGE1 to extend matriglycan on α-dystroglycan and prevents muscular dystrophy.
Okuma H; Hord JM; Chandel I; Venzke D; Anderson ME; Walimbe AS; Joseph S; Gastel Z; Hara Y; Saito F; Matsumura K; Campbell KP
Elife; 2023 Feb; 12():. PubMed ID: 36723429
[TBL] [Abstract][Full Text] [Related]
8. AGO61-dependent GlcNAc modification primes the formation of functional glycans on α-dystroglycan.
Yagi H; Nakagawa N; Saito T; Kiyonari H; Abe T; Toda T; Wu SW; Khoo KH; Oka S; Kato K
Sci Rep; 2013 Nov; 3():3288. PubMed ID: 24256719
[TBL] [Abstract][Full Text] [Related]
9. Carbohydrate-binding domain of the POMGnT1 stem region modulates O-mannosylation sites of α-dystroglycan.
Kuwabara N; Manya H; Yamada T; Tateno H; Kanagawa M; Kobayashi K; Akasaka-Manya K; Hirose Y; Mizuno M; Ikeguchi M; Toda T; Hirabayashi J; Senda T; Endo T; Kato R
Proc Natl Acad Sci U S A; 2016 Aug; 113(33):9280-5. PubMed ID: 27493216
[TBL] [Abstract][Full Text] [Related]
10. Absence of post-phosphoryl modification in dystroglycanopathy mouse models and wild-type tissues expressing non-laminin binding form of α-dystroglycan.
Kuga A; Kanagawa M; Sudo A; Chan YM; Tajiri M; Manya H; Kikkawa Y; Nomizu M; Kobayashi K; Endo T; Lu QL; Wada Y; Toda T
J Biol Chem; 2012 Mar; 287(12):9560-7. PubMed ID: 22270369
[TBL] [Abstract][Full Text] [Related]
11. [Recent Advances in α-dystroglycanopathy].
Kuga A; Kanagawa M; Toda T
Brain Nerve; 2011 Nov; 63(11):1189-95. PubMed ID: 22068471
[TBL] [Abstract][Full Text] [Related]
12. Deficiency of alpha-dystroglycan in muscle-eye-brain disease.
Kano H; Kobayashi K; Herrmann R; Tachikawa M; Manya H; Nishino I; Nonaka I; Straub V; Talim B; Voit T; Topaloglu H; Endo T; Yoshikawa H; Toda T
Biochem Biophys Res Commun; 2002 Mar; 291(5):1283-6. PubMed ID: 11883957
[TBL] [Abstract][Full Text] [Related]
13. Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE.
Inamori K; Yoshida-Moriguchi T; Hara Y; Anderson ME; Yu L; Campbell KP
Science; 2012 Jan; 335(6064):93-6. PubMed ID: 22223806
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of LARGE suppresses muscle regeneration via down-regulation of insulin-like growth factor 1 and aggravates muscular dystrophy in mice.
Saito F; Kanagawa M; Ikeda M; Hagiwara H; Masaki T; Ohkuma H; Katanosaka Y; Shimizu T; Sonoo M; Toda T; Matsumura K
Hum Mol Genet; 2014 Sep; 23(17):4543-58. PubMed ID: 24722207
[TBL] [Abstract][Full Text] [Related]
15. Exogenous expression of the glycosyltransferase LARGE1 restores α-dystroglycan matriglycan and laminin binding in rhabdomyosarcoma.
Beltrán D; Anderson ME; Bharathy N; Settelmeyer TP; Svalina MN; Bajwa Z; Shern JF; Gultekin SH; Cuellar MA; Yonekawa T; Keller C; Campbell KP
Skelet Muscle; 2019 May; 9(1):11. PubMed ID: 31054580
[TBL] [Abstract][Full Text] [Related]
16. Differential glycosylation of α-dystroglycan and proteins other than α-dystroglycan by like-glycosyltransferase.
Zhang P; Hu H
Glycobiology; 2012 Feb; 22(2):235-47. PubMed ID: 21930648
[TBL] [Abstract][Full Text] [Related]
17. SGK196 is a glycosylation-specific O-mannose kinase required for dystroglycan function.
Yoshida-Moriguchi T; Willer T; Anderson ME; Venzke D; Whyte T; Muntoni F; Lee H; Nelson SF; Yu L; Campbell KP
Science; 2013 Aug; 341(6148):896-9. PubMed ID: 23929950
[TBL] [Abstract][Full Text] [Related]
18. CDP-glycerol inhibits the synthesis of the functional
Imae R; Manya H; Tsumoto H; Osumi K; Tanaka T; Mizuno M; Kanagawa M; Kobayashi K; Toda T; Endo T
J Biol Chem; 2018 Aug; 293(31):12186-12198. PubMed ID: 29884773
[TBL] [Abstract][Full Text] [Related]
19. The role of defective glycosylation in congenital muscular dystrophy.
Schachter H; Vajsar J; Zhang W
Glycoconj J; 2004; 20(5):291-300. PubMed ID: 15229394
[TBL] [Abstract][Full Text] [Related]
20. Congenital muscular dystrophies involving the O-mannose pathway.
Martin PT
Curr Mol Med; 2007 Jun; 7(4):417-25. PubMed ID: 17584082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
